Janux Therapeutics
Roger Martin, CPA has been working in the accounting industry since 2016. Roger'sfirst role was as a Staff Accountant at Plumb, followed by a role as an Account Administration Representative at Kaiser Permanente. In 2017, they moved to Sempra Energy as a Staff Accountant and then to San Diego Gas & Electric in 2019, where they held roles as a Financial Business Analysis and Billable Project Accounting. In 2022, Roger began working as a Senior Accountant at Janux Therapeutics.
Roger Martin, CPA obtained a Bachelor of Science in Finance from San Diego State University between 2013 and 2015. In August 2021, they obtained the Certified Public Accountant certification from the California Board of Accountancy.
Janux Therapeutics
1 followers
Janux Therapeutics is developing safe, effective novel immunotherapies with the company’s proprietary TRACTr technology. Janux’s TRACTr technology employs a modular design to rapidly engineer drug candidates against specific targets.